The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
書誌事項
- タイトル
- The novel CXCR4 antagonist, KRH-3955 is an orally bioavailable and extremely potent inhibitor of human immunodeficiency virustype 1 infection : comparative studies with AMD3100
- 著者
- Tsutomu Murakami
収録刊行物
-
- Antimicrobial Agents and Chemotherapy 53(7)
-
Antimicrobial Agents and Chemotherapy 53(7) 2940-2948, 2009
- Tweet
詳細情報
-
- CRID
- 1010282257024441481
-
- 資料種別
- journal article
-
- データソース種別
-
- KAKEN